Slotkin Theodore A, Skavicus Samantha, Card Jennifer, Giulio Richard T Di, Seidler Frederic J
Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC, 27710, USA.
Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC, 27710, USA.
Toxicology. 2017 Feb 15;377:49-56. doi: 10.1016/j.tox.2016.12.008. Epub 2016 Dec 31.
In addition to their carcinogenic activity, polycyclic aromatic hydrocarbons (PAHs) are suspected to be developmental neurotoxicants. We evaluated the effects of PAHs with two in vitro models that assess distinct "decision nodes" in neurodifferentiation: neuronotypic PC12 cells, which characterize the transition from cell replication to neurodifferentiation, neurite outgrowth and neurotransmitter specification; and embryonic neural stem cells (NSCs), which evaluate the origination of neurons and glia from precursors. We compared an environmentally-derived PAH mixture from a Superfund contamination site (Elizabeth River Sediment Extract, ERSE) to those of a single PAH, benzo[a]pyrene (BaP). In PC12 cells, BaP impaired the transition from cell replication to neurodifferentiation, resulting in higher numbers of cells, but with reduced cell size and deficits in all indices of neuronal features (neurite formation, development of dopamine and acetylcholine phenotypes). ERSE was far less effective, causing only modest changes in cell numbers and size and no impairment of neurite formation or neurotransmitter specification; in fact, ERSE evoked a slight increase in emergence of the acetylcholine phenotype. In the NSC model, this relationship was entirely reversed, with far greater sensitivity to ERSE than to BaP. Furthermore, ERSE, but not BaP, enhanced NSC differentiation into neurons, whereas both ERSE and BaP suppressed the glial phenotype. Our studies provide a cause-and-effect relationship for the observed association of developmental PAH exposure to behavioral deficits. Further, PAH sensitivity occurs over developmental stages corresponding to rudimentary brain formation through terminal neurodifferentiation, suggesting that vulnerability likely extends throughout fetal brain development and into early childhood.
除了具有致癌活性外,多环芳烃(PAHs)还被怀疑是发育性神经毒物。我们使用两种体外模型评估了PAHs的影响,这两种模型评估神经分化过程中不同的“决策节点”:神经元样PC12细胞,其表征从细胞复制到神经分化、神经突生长和神经递质特异性的转变;以及胚胎神经干细胞(NSCs),其评估神经元和神经胶质从前体的起源。我们将一种来自超级基金污染场地的环境衍生PAH混合物(伊丽莎白河沉积物提取物,ERSE)与单一PAH苯并[a]芘(BaP)的影响进行了比较。在PC12细胞中,BaP损害了从细胞复制到神经分化的转变,导致细胞数量增加,但细胞尺寸减小,并且神经元特征的所有指标(神经突形成、多巴胺和乙酰胆碱表型的发育)都存在缺陷。ERSE的效果要差得多,仅引起细胞数量和大小的适度变化,且不损害神经突形成或神经递质特异性;事实上,ERSE引起乙酰胆碱表型的出现略有增加。在NSC模型中,这种关系完全相反,对ERSE的敏感性远高于对BaP的敏感性。此外,ERSE而非BaP增强了NSC向神经元的分化,而ERSE和BaP都抑制了神经胶质表型。我们的研究为观察到的发育性PAH暴露与行为缺陷之间的关联提供了因果关系。此外,PAH敏感性发生在从原始脑形成到终末神经分化的发育阶段,这表明易感性可能贯穿胎儿脑发育直至幼儿期。